Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-α therapy.

Gaudiello, Francesca (2011) Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-α therapy. [Tesi di dottorato] (Inedito)

Full text disponibile come:

[img]PDF - Solo per gli Amministratori dell'archivio fino a 18 Gennaio 2013 - Richiede un editor Pdf del tipo GSview, Xpdf o Adobe Acrobat Reader
422Kb

Abstract

Osteopontin (OPN) an aspartic acid-rich, N-linked glycosylated protein, is a secreted adhesive molecule, and it is thought to aid in the recruitment of monocytes-macrophages and to regulate cytokine production in macrophages, dendritic cells, and T-cells. Psoriasis is an immune-mediated inflammatory disorder, where Th1 and Th17 lymphocytes contribute to the pathogenesis through the release of inflammatory cytokines that promote further recruitment of immune cells, keratinocyte proliferation and sustained inflammation. Tumor necrosis factor alpha (TNF-α) is a pleiotropic cytokine with a central role in the pathogenesis of psoriasis. Among the multiple effects produced by TNF-α on keratinocytes, the induction of matrix metalloproteinase 9 (MMP-9) a collagenase implicated in psoriasis, might represent a key mechanism in the pathogenesis of the disease. Biological therapy based on monoclonal antibodies against TNF-α has been proven to be effective in patients with psoriasis. Aim of the present study was to investigate the relationship between OPN, MMP-9 and TNF-α in psoriasis, by assessing the presence of OPN and MMP-9 in PBMC and sera of 7 psoriatic patients before and after anti-TNF-α treatment. We demonstrated that TNF-α antagonists (etanercept and adalimumab) were able to decrease OPN either in PBMC or in plasma. Our findings showed also anti TNF-α treatment reduced also MMP-9 expression in PBMC of psoriatic patients.

Tipologia di documento:Tesi di dottorato
Parole chiave:psoriasis; osteopontin; anti-TNF-alpha
Settori scientifico-disciplinari MIUR:Area 06 Scienze mediche > MED/35 MALATTIE CUTANEE E VENEREE
Coordinatori della Scuola di dottorato:
Coordinatore del Corso di dottoratoe-mail (se nota)
Marone, Gianni
Tutor della Scuola di dottorato:
Tutor del Corso di dottoratoe-mail (se nota)
Ayala, Fabioayala@unina.it
Stato del full text:Inedito
Data:30 Novembre 2011
Numero di pagine:24
Istituzione:Università di Napoli Federico II
Dipartimento o Struttura:Patologia sistematica
Stato dell'Eprint:Inedito
Scuola di dottorato:Medicina clinica e sperimentale
Denominazione del dottorato:Fisiopatologia clinica e medicina sperimentale
Ciclo di dottorato:24
Numero di sistema:8758
Depositato il:07 Dicembre 2011 10:24
Ultima modifica:11 Maggio 2012 11:05

Solo per gli Amministratori dell'archivio: edita il record